Advertisement
Screener

ConocoPhillips (COP) Clinical Trials

ConocoPhillips Clinical Trials

Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.

  • 2003-08: Study NCT00365014; Company role Collaborator; Phase Observational; Status Completed.
  • 2003-08: Study NCT00364520; Company role Collaborator; Phase Observational; Status Completed.
Start dateStudyCompany rolePhaseStatusConditionsEnrollmentCompletion date
2003-08NCT00365014
Progression of Hematopoietic Diseases in Shanghai, China
Collaborator
Lead: University of Colorado, Denver
ObservationalCompletedHematologic Diseases10,7572009-12
2003-08NCT00364520
Molecular Epidemiology of Benzene-exposed Workers.
Collaborator
Lead: University of Colorado, Denver
ObservationalCompletedHematologic Diseases2,0002009-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
VALERO ENERGY CORP/TX (VLO)United States$110.282B10.72
Marathon Petroleum Corp (MPC)United States$109.683B8.72
Phillips 66 (PSX)United States$102.103B9.51
IMPERIAL OIL LTD (IMO)$60.241B
CVR ENERGY INC (CVI)United States$5.161B16.17
ICAHN ENTERPRISES L.P. (IEP)United States$4.941B-9.21
Calumet, Inc. /DE (CLMT)United States$4.731B-23.12
Delek US Holdings, Inc. (DK)United States$4.096B13.87
SunocoCorp LLC (SUNC)United States$3.977B
CHEVRON CORP (CVX)United States$406.278B15.91